Pay-for-Delay Is Heading Toward Supreme Court Again
WASHINGTON – In a decision that's likely to head to the Supreme Court, a federal appellate court struck down pay-for-delay settlements between makers of brand and generic drugs, claiming they violate antitrust laws.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST